Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Short-Term Debt issuancesShort-Term Debt repayments
Ratios

Myriad Genetics (MYGN) Shares Issued (2016 - 2024)

Historic Shares Issued for Myriad Genetics (MYGN) over the last 16 years, with Q4 2024 value amounting to $2.9 million.

  • Myriad Genetics' Shares Issued fell 9753.4% to $2.9 million in Q4 2024 from the same period last year, while for Sep 2025 it was $120.5 million, marking a year-over-year increase of 246.6%. This contributed to the annual value of $5.9 million for FY2024, which is 9498.3% down from last year.
  • As of Q4 2024, Myriad Genetics' Shares Issued stood at $2.9 million, which was down 9753.4% from $117.6 million recorded in Q4 2023.
  • Myriad Genetics' 5-year Shares Issued high stood at $117.6 million for Q4 2023, and its period low was $300000.0 during Q1 2020.
  • In the last 5 years, Myriad Genetics' Shares Issued had a median value of $2.3 million in 2020 and averaged $16.1 million.
  • In the last 5 years, Myriad Genetics' Shares Issued surged by 873333.33% in 2021 and then crashed by 9886.79% in 2022.
  • Myriad Genetics' Shares Issued (Quarter) stood at $1.8 million in 2020, then changed by 0.0% to $1.8 million in 2021, then surged by 33.33% to $2.4 million in 2022, then soared by 4800.0% to $117.6 million in 2023, then plummeted by 97.53% to $2.9 million in 2024.
  • Its Shares Issued was $2.9 million in Q4 2024, compared to $117.6 million in Q4 2023 and $2.4 million in Q4 2022.